Estrogen receptor positive (ER+) subtype (Oestrogen receptor or hormone receptor subtype) is the most vital discriminator of breast cancer, accounting for nearly 75% of all breast cancer cases [10]. Here, NR4A1 is linked to breast carcinoma.